BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.

BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.

INTRODUCTION:Brain-Derived Neurotrophic Factor (BDNF) and its most common polymorphism Val66Met are known to have a role in Multiple Sclerosis (MS) pathogenesis. Evidence is accumulating that there is an involvement of DNA methylation in the regulation of BDNF expression. The aim of this study was t...

Full description

Bibliographic Details
Main Authors: Viviana Nociti, Massimo Santoro, Davide Quaranta, Francesco Antonio Losavio, Chiara De Fino, Rocco Giordano, Nicole Piera Palomba, Paolo Maria Rossini, Franca Rosa Guerini, Mario Clerici, Domenico Caputo, Massimiliano Mirabella
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6198951?pdf=render

Internet

http://europepmc.org/articles/PMC6198951?pdf=render

Similar Items